Investor Presentation First Nine Months of 2022

31 Investor presentation First nine months of 2022 Novo NordiskⓇ Novo Nordisk has a global manufacturing setup Local production All products API, fill and finish Russia API, fill and finish Fill and finish Fill and finish Product Supply value chain ㅎ Research and Development Manufacturing development ΑΡΙ production API: Active Pharmaceutical Ingredient Iran Algeria Fill and finish Japan ເພີ້ມ ) ❖ : A ອອ பப்ப Filling / tableting Assembly and packaging Distribution (cold chain) Patients

View entire presentation